Our results indicated that PXR activation led to increased proliferation and MDR in colon cancer cells; however, the concurrent administration of FLCWK with 5‐FU effectively reversed the MDR linked to 5‐FU, offering significant implications for future clinical applications. This evidence concerns the gene NR1I2 and malignant colon neoplasm.